B
Bpifrance Portfolio holdings
AUM
$2.09B
This Quarter Return
+12.36%
1 Year Return
-46.97%
3 Year Return
-14.84%
5 Year Return
-4.77%
10 Year Return
–
AUM
$4.5B
AUM Growth
+$4.5B
(+14%)
Cap. Flow
+$32.2M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$32.7M |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
$518K |
Sector Composition
| 1 | Consumer Discretionary | 84.11% |
| 2 | Materials | 6.9% |
| 3 | Energy | 4.93% |
| 4 | Communication Services | 2.73% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stellantis
STLA
$27.8B
| $3.79B | 84.11% | 192,703,907 | – | – |
|
2
Constellium
CSTM
$2.02B
| $311M | 6.9% | 16,393,903 | – | – |
|
3
TechnipFMC
FTI
$15.1B
| $222M | 4.93% | 24,688,691 | – | – |
|
4
Criteo
CRTO
$1.3B
| $123M | 2.73% | 2,718,752 | – | – |
|
|
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $32.7M | 0.73% | +2,806,217 | New | +$32.7M |
|
|
SQNS
6
Sequans Communications
SQNS
$129M
| $19.9M | 0.44% | 3,300,018 | – | – |
|
|
CLLS
7
Cellectis
CLLS
$258M
| $6.59M | 0.15% | 425,726 | – | – |
|
|
8
CRISPR Therapeutics
CRSP
$4.71B
| $777K | 0.02% | 4,800 -3,200 | -40% | -$518K |
|